Review
doi: 10.1007/BF00273384.
Anthracycline analogs: the past, present, and future
- PMID: 2948729
- DOI: 10.1007/BF00273384
Item in Clipboard
Review
Anthracycline analogs: the past, present, and future
Cancer Chemother Pharmacol.
1986.
No abstract available
Similar articles
-
Phase I and II agents in cancer therapy: I. Anthracyclines and related compounds.J Clin Pharmacol. 1986 Sep-Oct;26(7):491-509. doi: 10.1002/j.1552-4604.1986.tb02942.x. J Clin Pharmacol. 1986. PMID: 2944917 Review.
-
Clinical assessment of the structure-activity relationship of anthracyclines and related synthetic derivatives.Cancer Treat Rep. 1986 Jan;70(1):51-63. Cancer Treat Rep. 1986. PMID: 2935251 Review. No abstract available.
-
New anthracycline antitumor antibiotics.Crit Rev Oncol Hematol. 1991;11(1):43-64. doi: 10.1016/1040-8428(91)90017-7. Crit Rev Oncol Hematol. 1991. PMID: 1831987 Review.
-
Intracellular uptake of 7-con-o-methylnogarol and adriamycin by cells in culture and its relationship to cell survival.Cancer Res. 1981 Mar;41(3):882-7. Cancer Res. 1981. PMID: 6450639 No abstract available.
-
Clinical studies with new anthracyclines: epirubicin, idarubicin, esorubicin.Drugs Exp Clin Res. 1986;12(1-3):233-46. Drugs Exp Clin Res. 1986. PMID: 3525075 Review.
Cited by
-
Antitumor activity of ME2303, a fluorine-containing anthracycline, against human tumors implanted in nude mice.Jpn J Cancer Res. 1989 Jul;80(7):686-9. doi: 10.1111/j.1349-7006.1989.tb01697.x. Jpn J Cancer Res. 1989. PMID: 2507492 Free PMC article.
-
Chronic vascular toxicity of doxorubicin in an organ-cultured artery.Br J Pharmacol. 2001 Apr;132(7):1365-73. doi: 10.1038/sj.bjp.0703959. Br J Pharmacol. 2001. PMID: 11264228 Free PMC article.
-
Differences in lipoprotein concentration and composition modify the plasma distribution of free and liposomal annamycin.Pharm Res. 1996 Mar;13(3):462-8. doi: 10.1023/a:1016065114515. Pharm Res. 1996. PMID: 8692743
-
C609T Polymorphism of NADPH Quinone Oxidoreductase 1 Correlates Clinical Hematological Toxicities in Lung Cancer Patients Treated with Amrubicin.Clin Med Insights Oncol. 2013;7:31-9. doi: 10.4137/CMO.S10839. Epub 2013 Feb 13. Clin Med Insights Oncol. 2013. PMID: 23467445 Free PMC article.
-
Identification of anthracyclines and related agents that retain preferential activity over adriamycin in multidrug-resistant cell lines, and further resistance modification by verapamil and cyclosporin A.Cancer Chemother Pharmacol. 1989;24(5):284-90. doi: 10.1007/BF00304759. Cancer Chemother Pharmacol. 1989. PMID: 2547527
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Miscellaneous